In a major breakthrough, National Health Service (NHS) has approved the first drug for sickle cell disease in 20 years.
The "revolutionary" treatment, called the Crizanlizumab, will help over 5,000 people with the condition in the next three years, NHS said in a statement. It will also slash the number of times a sickle cell disease patient needs to go to A&E by two-fifths.